These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 538246)

  • 1. Carcinogenesis of N-nitroso-morpholine and derivatives in Syrian golden hamsters.
    Mohr U
    Prog Exp Tumor Res; 1979; 24():235-44. PubMed ID: 538246
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenesis by nitrosomorpholines, nitrosooxazolidines and nitrosoazetidine given by gavage to Syrian golden hamsters.
    Lijinsky W; Kovatch RM; Knutsen GL
    Carcinogenesis; 1984 Jul; 5(7):875-8. PubMed ID: 6733849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relations in carcinogenesis by N-nitroso compounds.
    Lijinsky W
    Cancer Metastasis Rev; 1987; 6(3):301-56. PubMed ID: 3319273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies with different doses of N-nitrosomorpholine, N-nitrosopiperidine, N-nitrosomethylurea, and dimethylnitrosamine in Syrian golden hamsters.
    Haas H; Mohr U; Krüger FW
    J Natl Cancer Inst; 1973 Oct; 51(4):1295-301. PubMed ID: 4745858
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrasting responses of rats and Syrian hamsters to orally administered N-nitroso compounds.
    Lijinsky W
    IARC Sci Publ; 1984; (57):617-26. PubMed ID: 6533056
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the carcinogenic effectiveness of N-nitrosobis(2-hydroxypropyl)amine, N-nitrosobis(2-oxopropyl)amine, N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, and N-nitroso-2,6-dimethylmorpholine in Syrian hamsters.
    Lijinsky W; Saavedra JE; Knutsen GL; Kovatch RM
    J Natl Cancer Inst; 1984 Mar; 72(3):685-8. PubMed ID: 6583451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in nitrosamine carcinogenesis.
    Lijinsky W
    J Cancer Res Clin Oncol; 1984; 108(1):46-55. PubMed ID: 6746715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common metabolites of N-nitroso-2,6-dimethylomorpholine and N-nitroso-bis(2-oxopropyl)amine in the Syrian hamster.
    GingellR ; Wallcave L; Nagel D; Kupper R; Pour P
    Cancer Lett; 1976 Sep; 2(1):47-52. PubMed ID: 1035131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic effect of subcutaneously administered N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters.
    Althoff J; Grandjean C; Gold B
    J Natl Cancer Inst; 1978 Jan; 60(1):197-9. PubMed ID: 628016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenesis and mutagenesis by N-nitroso compounds having a basic center.
    Lijinsky W; Kovatch RM; Saavedra JE
    Cancer Lett; 1992 Apr; 63(2):101-7. PubMed ID: 1562986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure of pancreatic tumors induced in Syrian hamsters by N-nitroso-2,6-dimethylmorpholine.
    Reznik-Schüller H
    Vet Pathol; 1980 May; 17(3):352-61. PubMed ID: 7368527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylation of DNA related to organ-specific carcinogenesis by N-nitroso compounds.
    Lijinsky W
    IARC Sci Publ; 1991; (105):305-10. PubMed ID: 1855869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting carcinogenic effects of nitroso-2,6-dimethylmorpholine given by gavage to F344 rats and Syrian golden hamsters.
    Lijinsky W; Reuber MD; Reznik-Schüller HM
    Cancer Lett; 1982 Sep; 16(3):281-6. PubMed ID: 7151048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model studies in tobacco carcinogenesis with the Syrian golden hamster.
    Hoffmann D; Rivenson A; Hecht SS; Hilfrich J; Kobayashi N; Wynder EL
    Prog Exp Tumor Res; 1979; 24():370-90. PubMed ID: 395571
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinogenic effect of N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters.
    Reznik G; Mohr U; Lijinsky W
    J Natl Cancer Inst; 1978 Feb; 60(2):371-8. PubMed ID: 202716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental pancreatic carcinogenesis. II. Lifetime carcinogenesis studies in the outbred Syrian golden hamster with N-nitroso-bis(2-hydroxypropyl)amine.
    Levitt M; Harris C; Squire R; Wenk M; Mollelo C; Springer S
    J Natl Cancer Inst; 1978 Mar; 60(3):701-5. PubMed ID: 625072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
    Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
    J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioassay for carcinogenicity of 3,2'-dimethyl-4-nitrosobiphenyl, O-nitrosotoluene, nitrosobenzene and the corresponding amines in Syrian golden hamsters.
    Hecht SS; El-Bayoumy K; Rivenson A; Fiala ES
    Cancer Lett; 1983 Oct; 20(3):349-54. PubMed ID: 6627231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of neoplastic response to a single dose of nitroso compounds. 3. The effect of N-nitrosopiperidine and N-nitrosomorpholine in Syrian golden hamsters.
    Althoff J; Wilson R; Cardesa A; Pour P
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(3-4):251-9. PubMed ID: 4279521
    [No Abstract]   [Full Text] [Related]  

  • 20. A further pancreatic carcinogen in Syrian golden hamsters: N-nitroso-bis(2-acetoxypropyl)amine.
    Pour P; Althoff J; Gingell R; Kupper R
    Cancer Lett; 1976 Mar; 1(4):197-202. PubMed ID: 1016944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.